Argitalpenak (70) María Jara Acevedo argitalpenak

2024

  1. Clinical impact of the TPSAB1 genotype in mast cell diseases: A REMA study in a cohort of 959 individuals

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 79, Núm. 3, pp. 711-723

  2. Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo

    Science translational medicine, Vol. 16, Núm. 734, pp. eadg7962

  3. T-cell immune profile in blood of systemic mastocytosis: Association with disease features

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 79, Núm. 7, pp. 1921-1937

2023

  1. Bone and Cytokine Markers Associated With Bone Disease in Systemic Mastocytosis

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 5, pp. 1536-1547

  2. In-depth blood immune profiling of Good syndrome patients

    Frontiers in Immunology, Vol. 14

  3. KITD816V mutation in blood for the diagnostic screening of systemic mastocytosis and mast cell activation syndromes

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 5, pp. 1347-1359

  4. Lymphocytic variant hypereosinophilic syndrome successfully treated with hematopoietic stem cell transplantation: A treatment challenge

    Pediatric Blood and Cancer

  5. Mast Cell Activation Syndromes: Comparison Between Two Scoring Models to Predict for Mast Cell Clonality

    The journal of allergy and clinical immunology. In practice, Vol. 11, Núm. 3, pp. 908-919

2022

  1. Altered innate immune profile in blood of systemic mastocytosis patients

    Clinical and Translational Allergy, Vol. 12, Núm. 6

  2. Frequency and prognostic impact of blood-circulating tumor mast cells in mastocytosis

    Blood, Vol. 139, Núm. 4, pp. 572-583

2021

  1. Proposed global prognostic score for systemic mastocytosis: a retrospective prognostic modelling study

    The Lancet Haematology, Vol. 8, Núm. 3, pp. e194-e204

  2. Whole-Exome Sequencing Reveals Recurrent but Heterogeneous Mutational Profiles in Sporadic WHO Grade 1 Meningiomas

    Frontiers in Oncology, Vol. 11

2020

  1. Age Distribution of Multiple Functionally Relevant Subsets of CD4+ T Cells in Human Blood Using a Standardized and Validated 14-Color EuroFlow Immune Monitoring Tube

    Frontiers in Immunology, Vol. 11

  2. Analysis of gene variants in the GASH/Sal model of epilepsy

    PLoS ONE, Vol. 15, Núm. 3

  3. Erratum: Analysis of gene variants in the GASH/Sal model of epilepsy (PLoS ONE (2020) 15:3 (e0229953) DOI: 10.1371/journal.pone.0229953)

    PLoS ONE

  4. Heterogeneous EGFR, CDK4, MDM4, and PDGFRA gene expression profiles in primary GBM: No association with patient survival

    Cancers, Vol. 12, Núm. 1

  5. STAT3 and STAT5B mutations in T/NK-cell chronic lymphoproliferative disorders of large granular lymphocytes (LGL): Association with disease features

    Cancers, Vol. 12, Núm. 12, pp. 1-20

2019

  1. Bone marrow mast cell antibody-targetable cell surface protein expression profiles in systemic mastocytosis

    International Journal of Molecular Sciences, Vol. 20, Núm. 3

  2. Complete Multilineage CD4 Expression Defect Associated With Warts Due to an Inherited Homozygous CD4 Gene Mutation

    Frontiers in Immunology, Vol. 10

  3. Frequency and prognostic impact of KIT and other genetic variants in indolent systemic mastocytosis

    Blood, Vol. 134, Núm. 5, pp. 456-468